Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rh-BNP for Recovery Stage of Septic Shock
NCT06745206Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Open-label, single-arm trial of nesiritide in septic shock and cardiomyopathy, sponsored by Sichuan Provincial People's Hospital. Primary endpoint: The pressure gradient of venous return at 30 minutes. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
nesiritide
03
Conditions
septic shockcardiomyopathy
Beyond the preview
Go deeper on NCT06745206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06745206.